FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry, namely to antibacterial pharmaceutical composition for oral administration. Antibacterial pharmaceutical composition for oral administration containing bacteriophages: Sextaphage® (polyvalent piobacteriophage), or Intesti-bacteriophage, or salmonellosis of groups A, B, C, D, E, or dysentery polyvalent, using as a target additives methylcellulose, sorbitol, lactose and calcium carbonate, calcium or magnesium stearate, sodium alginate, pectin, composition is packaged in solid capsules at a certain ratio of components.
EFFECT: expands the range of medicinal forms of bacteriophages.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | 2012 |
|
RU2520346C2 |
BIOPHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL AND PROBIOTIC ACTIVITY AND DOSAGE FORM BASED ON IT | 2021 |
|
RU2795770C2 |
BACTERIOPHAGE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2241446C2 |
ANTIBACTERIAL COMPOSITION, STRAIN OF BACTERIOPHAGE Escherichia coli, USED FOR OBTAINING THEREOF | 2012 |
|
RU2518303C2 |
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
METHOD FOR PREPARING POLYBACTERIOPHAGE | 2002 |
|
RU2247151C2 |
METHOD OF BACTERIOPHAGE ISOLATION | 1996 |
|
RU2109055C1 |
Authors
Dates
2018-07-05—Published
2016-04-01—Filed